An Evaluation of the Complement-Regulating Activities of Human Complement Factor H (FH) Variants Associated With Age-Related Macular Degeneration

Overview

Journal Invest Ophthalmol Vis Sci

Specialty Ophthalmology

Date 2022 Nov 29

PMID 36445700

Authors

Robyn M Biggs

Elisavet Makou

Scott Lauder

Andrew P Herbert

Paul N Barlow

Suresh K Katti

Affiliations

Soon will be listed here.

Abstract

Purpose: Factor H (FH, encoded by CFH) prevents activation of the complement system's alternative pathway (AP) on host tissues. FH impedes C3 convertase (C3bBb) formation, accelerates C3bBb decay, and is a cofactor for factor I (FI)-catalyzed C3b cleavage. Numerous CFH variants are associated with age-related macular degeneration (AMD), but their functional consequences frequently remain undetermined. Here, we conduct functional comparisons between a control version of FH (not AMD linked) and 21 AMD-linked FH variants.

Methods: Recombinantly produced, untagged, full-length FH versions were assayed for binding to C3b and decay acceleration of C3bBb using surface-plasmon resonance, FI-cofactor activity using a fluorescent probe of C3b integrity, suppression of C5b-9 assembly on an AP-activating surface, and inhibition of human AP-mediated lysis of sheep erythrocytes.

Results: All versions were successfully purified despite below-average yields for Arg2Thr, Arg53Cys, Arg175Pro, Arg175Gln, Ile221Val, Tyr402His, Pro503Ala, Arg567Gly, Gly1194Asp, and Arg1210Cys. Compared to control FH, Arg2Thr, Leu3Val, Ser58Ala, Asp90Gly, Asp130Asn, Gln400Lys, Tyr402His, Gly650Val, Ser890Ile, and Thr965Met showed minimal functional differences. Arg1210C, Arg53His, Arg175Gln, Gly1194Asp, Pro503Ala, Arg53Cys, Arg576Gly, and Arg175Pro (in order of decreasing efficacy) underperformed, while Ile221Val, Arg303Gln, and Arg303Trp were "marginal." We newly identified variants toward the center of the molecule, Pro503Ala and Arg567Gly, as potentially pathogenic.

Conclusions: Our approach could be extended to other variants of uncertain significance and to assays for noncanonical FH activities, aiming to facilitate selection of cohorts most likely to benefit from therapeutic FH. This is timely as recombinant therapeutic FH is in development for intravitreal treatment of AMD in patients with reduced FH functionality.

Citing Articles

Moss-produced human complement factor H with modified glycans has an extended half-life and improved biological activity.

Tschongov T, Konwar S, Busch A, Sievert C, Hartmann A, Noris M Front Immunol. 2024; 15:1383123.

PMID: 38799460 PMC: 11117068. DOI: 10.3389/fimmu.2024.1383123.

References

Ferrara D, Seddon J . Phenotypic Characterization of Complement Factor H R1210C Rare Genetic Variant in Age-Related Macular Degeneration. JAMA Ophthalmol. 2015; 133(7):785-91. PMC: 6516461. DOI: 10.1001/jamaophthalmol.2015.0814. View

Fritsche L, Igl W, Cooke Bailey J, Grassmann F, Sengupta S, Bragg-Gresham J . A large genome-wide association study of age-related macular degeneration highlights contributions of rare and common variants. Nat Genet. 2015; 48(2):134-43. PMC: 4745342. DOI: 10.1038/ng.3448. View

Schmidt C, Herbert A, Mertens H, Guariento M, Soares D, Uhrin D . The central portion of factor H (modules 10-15) is compact and contains a structurally deviant CCP module. J Mol Biol. 2009; 395(1):105-22. PMC: 2806952. DOI: 10.1016/j.jmb.2009.10.010. View

Kerr H, Wong E, Makou E, Yang Y, Marchbank K, Kavanagh D . Disease-linked mutations in factor H reveal pivotal role of cofactor activity in self-surface-selective regulation of complement activation. J Biol Chem. 2017; 292(32):13345-13360. PMC: 5555194. DOI: 10.1074/jbc.M117.795088. View

Xue X, Wu J, Ricklin D, Forneris F, Di Crescenzio P, Schmidt C . Regulator-dependent mechanisms of C3b processing by factor I allow differentiation of immune responses. Nat Struct Mol Biol. 2017; 24(8):643-651. PMC: 5773341. DOI: 10.1038/nsmb.3427. View

Holliday E, Smith A, Cornes B, Buitendijk G, Jensen R, Sim X . Insights into the genetic architecture of early stage age-related macular degeneration: a genome-wide association study meta-analysis. PLoS One. 2013; 8(1):e53830. PMC: 3543264. DOI: 10.1371/journal.pone.0053830. View

Black J, Clark S . Age-related macular degeneration: genome-wide association studies to translation. Genet Med. 2015; 18(4):283-9. PMC: 4823638. DOI: 10.1038/gim.2015.70. View

Fett A, Hermann M, Muether P, Kirchhof B, Fauser S . Immunohistochemical localization of complement regulatory proteins in the human retina. Histol Histopathol. 2012; 27(3):357-64. DOI: 10.14670/HH-27.357. View

Martin Merinero H, Zhang Y, Arjona E, Del Angel G, Goodfellow R, Gomez-Rubio E . Functional characterization of 105 factor H variants associated with aHUS: lessons for variant classification. Blood. 2021; 138(22):2185-2201. PMC: 8641096. DOI: 10.1182/blood.2021012037. View

10.

Hourcade D, Mitchell L, Kuttner-Kondo L, Atkinson J, Medof M . Decay-accelerating factor (DAF), complement receptor 1 (CR1), and factor H dissociate the complement AP C3 convertase (C3bBb) via sites on the type A domain of Bb. J Biol Chem. 2001; 277(2):1107-12. DOI: 10.1074/jbc.M109322200. View

11.

Makou E, Herbert A, Barlow P . Functional anatomy of complement factor H. Biochemistry. 2013; 52(23):3949-62. DOI: 10.1021/bi4003452. View

12.

Kamala O, Malik T, Hallam T, Cox T, Yang Y, Vyas F . Homodimeric Minimal Factor H: Tracking and Extended Dosing Studies in Factor H Deficient Mice. Front Immunol. 2021; 12:752916. PMC: 8696033. DOI: 10.3389/fimmu.2021.752916. View

13.

Haines J, Hauser M, Schmidt S, Scott W, Olson L, Gallins P . Complement factor H variant increases the risk of age-related macular degeneration. Science. 2005; 308(5720):419-21. DOI: 10.1126/science.1110359. View

14.

Barlow P, Steinkasserer A, Norman D, Kieffer B, Wiles A, Sim R . Solution structure of a pair of complement modules by nuclear magnetic resonance. J Mol Biol. 1993; 232(1):268-84. DOI: 10.1006/jmbi.1993.1381. View

15.

Isenman D . Conformational changes accompanying proteolytic cleavage of human complement protein C3b by the regulatory enzyme factor I and its cofactor H. Spectroscopic and enzymological studies. J Biol Chem. 1983; 258(7):4238-44. View

16.

Wong E, Hallam T, Brocklebank V, Walsh P, Smith-Jackson K, Shuttleworth V . Functional Characterization of Rare Genetic Variants in the N-Terminus of Complement Factor H in aHUS, C3G, and AMD. Front Immunol. 2021; 11:602284. PMC: 7840601. DOI: 10.3389/fimmu.2020.602284. View

17.

Geerlings M, de Jong E, den Hollander A . The complement system in age-related macular degeneration: A review of rare genetic variants and implications for personalized treatment. Mol Immunol. 2016; 84:65-76. PMC: 5380947. DOI: 10.1016/j.molimm.2016.11.016. View

18.

Hageman G, Anderson D, Johnson L, Hancox L, Taiber A, Hardisty L . A common haplotype in the complement regulatory gene factor H (HF1/CFH) predisposes individuals to age-related macular degeneration. Proc Natl Acad Sci U S A. 2005; 102(20):7227-32. PMC: 1088171. DOI: 10.1073/pnas.0501536102. View

19.

Klein R, Zeiss C, Chew E, Tsai J, Sackler R, Haynes C . Complement factor H polymorphism in age-related macular degeneration. Science. 2005; 308(5720):385-9. PMC: 1512523. DOI: 10.1126/science.1109557. View

20.

de Breuk A, Heesterbeek T, Bakker B, Verzijden T, Lechanteur Y, Klaver C . Evaluating the Occurrence of Rare Variants in the Complement Factor H Gene in Patients With Early-Onset Drusen Maculopathy. JAMA Ophthalmol. 2021; 139(11):1218-1226. PMC: 8517879. DOI: 10.1001/jamaophthalmol.2021.4102. View